<DOC>
	<DOCNO>NCT02604771</DOCNO>
	<brief_summary>This study epidemiological non-interventional trial aim evaluate standard daily practice manage patient arterial hypertension . The trial record real-life clinical practice additional diagnostic monitoring procedure . The study purpose collect follow Egypt-specific epidemiology data hypertension : demographic data , patient ' characteristic , patient ' management/treatment order reach rationale .</brief_summary>
	<brief_title>Egypt Hypertension Study</brief_title>
	<detailed_description>This study aim evaluate response rate antihypertensive treatment Thiazide Diuretics , calcium antagonist , Angiotensin Converting enzyme Inhibitor , Angiotensin II receptor blocker , Beta Blocker real life practice , collect follow Egypt-specific epidemiology data hypertensive patient : demographic data , patent characteristic , patient ' management/treatment . Approximately 300 site participate ( 1 investigator per site ; 300 investigator ) . Patients enrol either newly diagnose hypertension , current antihypertensive treatment , compile total 3000 patient ( 21 year , old ) . The study conduct two sequential phase ; first phase include 150 site Cairo , Giza Alexandria aim reach 1500 patient follow second phase include 150 site Delta Upper Egypt aim reach 1500 patient . Epidemiological data collection take place single visit Laboratory Investigations request first visit . Patients follow 3 visit investigator . The investigator complete Patient Record Form ( PRF ) patient 's data : demographic , history , current antihypertensive drug treatment/treatment change , result physical examination , blood pressure ( SBP/DBP ) , heart rate .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Males female age &gt; 21 year Subject population newly diagnose essential arterial hypertension Subject population essential arterial hypertension currently receive treatment follow antihypertensive class : Thiazide Diuretics , calcium antagonist , Angiotensin Converting enzyme Inhibitor , Angiotensin II receptor blocker Beta Blocker least 3 month . Females childbearing potential must use reliable method contraception . Subject willing give write inform consent If participate clinical trial , subject take part study . Pregnancy lactation . Patients willing give Informed Consent .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>